ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 2.800
+0.800 (40.00%)
At close: Oct 8, 2026
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 85.09 million as of October 9, 2026. It is the 29,161st most valuable company in the world and the 796th biggest in Canada. Its market cap has decreased by 58.92% in one year.
Market Cap
85.09M
Enterprise Value
84.58M
Revenue
n/a
Global Rank
Country Rank
#796 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 85.09M, an increase of 489.61%. That is a compound annual growth rate of 80.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 85.09M | -29.21% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eastwood Bio-Medical Canada | 121.24M |
| Helix BioPharma | 70.27M |
| NurExone Biologic | 57.84M |
| BriaCell Therapeutics | 48.37M |
| MedMira | 45.61M |
| Sernova Biotherapeutics | 43.43M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 42.46M |